位置:成果数据库 > 期刊 > 期刊详情页
Cell-SELEX-based aptamer-conjugated nanomaterials for cancer diagnosis and therapy
  • 期刊名称:National Science Review
  • 时间:2015.1.1
  • 页码:71-84
  • 分类:R730[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:Molecular Science and Biomedicine Laboratory,State Key Laboratory of Chemo/Biosensing and Chemometrics,College of Chemistry and Chemical Engineering,College of Biology,Collaborative Innovation Center for Molecular Engineering for Theranostics,Hunan University
  • 相关基金:supported by the National Key Scientiic Program of China(2011CB911000);the National Natural Science Foundation of China(21221003);the China National Instrumentation Program(2011YQ03012412)
  • 相关项目:化学生物传感的分析化学基础研究
中文摘要:

Nucleic acid aptamers, which are generated by a novel technique called SELEX(systematic evolution of ligands by exponential enrichment), have recently atracted signiicant atention in the ield of early detection and treatment of cancer based on their numerous merits, such as high ainity, high speciicity,small size, litle immunogenicity, stable structures, and ease of chemical modiication. Furthermore,aptamers can gain more lexibility as cancer cell targeting tools when conjugated to nanomaterials,including metallic nanoparticles, carbon nanomaterials, DNA nanodevices, and polymeric nanoparticles.We discuss the progress achieved in cancer diagnosis and therapy through the conjugation of cell-SELEX-based aptamers with diferent nanomaterials.

英文摘要:

Nucleic acid aptamers, which are generated by a novel technique called SELEX (systematic evolution of ligands by exponential enrichment), have recently attracted significant attention in the field of early detection and treatment of cancer based on their numerous merits, such as high affinity, high specificity, small size, little immunogenicity, stable structures, and ease of chemical modification. Furthermore, aptamers can gain more flexibility as cancer cell targeting tools when conjugated to nanomaterials, including metallic nanoparticles, carbon nanomaterials, DNA nanodevices, and polymeric nanoparticles. We discuss the progress achieved in cancer diagnosis and therapy through the conjugation of cell-SELEX-based aptamers with different nanomaterials.

同期刊论文项目
同项目期刊论文